DUBLIN--(BUSINESS WIRE)--The "Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030: Based on Type of Solution, Type of Therapy and Purpose of Solution" report has been added to ResearchAndMarkets.com's offering.
This report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of digital therapeutics solutions (either commercialized or under development) in the healthcare industry, over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
Chronic disorders, such as arthritis, diabetes, cancer, obesity and heart disease, are considered to be the leading causes of death and disability across the world. Specifically, the global prevalence of diabetes is estimated to be more than 300 million adults by 2025. According to the WHO, more than 450 million people are presently suffering from some form of mental health disorder (such as anxiety and depression), and/or neurological disorder. The rise in number of patients suffering from such clinical conditions continues to impose a significant burden on the global healthcare system. Specifically, in the US, it was estimated that approximately 90% of the country's annual healthcare expenditure was on patients suffering from various chronic and mental health conditions.
Digital health solutions represent a relatively new concept, which was introduced into mainstream healthcare a few years ago. Such solutions are presently believed to possess the potential to reshape the practice of healthcare. Typically, digital therapeutics are available in the form of various types of gamified solutions, and/or standalone software applications, sometimes featuring active, personalized coaching support, or artificial intelligence (AI) enabled support.
The ongoing COVID-19 pandemic and the mandatory enforcement of social distancing measures have created a significant demand for remote healthcare solutions. In fact, China introduced a range of digital solutions throughout different stages of the outbreak, immediately after the coronavirus spread. Recently, the USFDA also issued certain guidelines on usability of digital therapeutics (specifically for psychiatric conditions), allowing patients to receive treatment at home, minimizing visits to clinics/hospitals, thereby, reducing risk of exposure to the novel coronavirus. Moreover, several companies are actively striving to create and launch solutions that not only allow patients to diagnose and confirm disease symptoms, and consult with doctors/physicians remotely, but also offer therapeutic aid. Although the focus of such companies is presently on diabetes, mental health disorders and musculoskeletal injuries, experts believe that digital therapeutics may eventually replace/augment traditional treatment measures, with clinically validated software.
Key Questions Answered
- Who are the leading developers offering digital therapeutic solutions?
- What are the most popular therapeutic areas for digital therapeutic solutions?
- Which companies are actively involved in conducting clinical trials for their solutions?
- What are the key factors influencing the price of digital therapeutic solutions?
- What is the trend in capital investments in the digital therapeutics market?
- Which partnership models are commonly adopted by stakeholders in this industry?
- What type of marketing strategies are being adopted by developers in this domain?
- What is the impact of COVID-19 outbreak on digital therapeutic solutions market?
- What are the opportunities for digital therapeutic solutions in emerging markets?
- How is the current and future opportunity likely to be distributed across key market segments?
- What are the anticipated future trends related to digital therapeutic solutions market?
Key Topics Covered:
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
4. CURRENT MARKET LANDSCAPE
5. PRODUCT COMPETITIVENESS ANALYSIS
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Akili Interactive
6.3. Big Health
6.5 Kaia Health
6.7. Omada Health
6.8. Pear Therapeutics
6.9. Vida Health
6.12. Wellthy Therapeutics
7. CLINICAL TRIAL ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Digital Therapeutics: Clinical Trial Analysis
7.4. Clinical End-Points Analysis
8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Types of Funding
8.3. Digital Therapeutics: Funding and Investment Analysis
8.3.1. Analysis by Number of Funding Instances
8.3.2. Analysis by Amount Invested
8.3.3. Analysis by Type of Funding
8.3.4. Analysis by Type of Therapy
8.3.5. Analysis by Therapeutic Area
8.3.6. Analysis by Geography
8.3.7. Most Active Players: Analysis by Number of Funding Instances
8.3.8. Most Active Players: Analysis by Amount of Funding
8.3.9. Most Active Investors: Analysis by Number of Instances
8.4 Concluding Remarks
9. PARTNERSHIPS AND COLLABORATIONS
10. GO-TO-MARKET STRATEGY
10.1. Chapter Overview
10.2. Marketing Strategies Adopted by Digital Therapeutic Developers
10.2.1. Participation in Global Events
10.2.2. Marketing on Social Media Platforms
10.2.3. Marketing on Online / Print Media Platforms
10.2.4. Undertaking Various Promotional Activities through Official Websites
10.2.5. Adoption of Different Business Models and Pricing Strategies
10.2.5.1. B2C Business Model
10.2.5.2. B2B Business Model
10.2.5.2. B2B2C Business Model
10.2.6. Undertaking Various Promotional Activities through Product Add-ons
10.3. Concluding Remarks
11. BOWMAN CLOCK PRICING STRATEGY ANALYSIS
12. MARKET FORECAST
13. CASE STUDY: IMPACT OF CORONAVIRUS OUTBREAK
14. REMOTE DIGITAL MONITORING / DIAGNOSTIC SOLUTIONS
14.1. Chapter Overview
14.2. An Introduction to Remote Digital Monitoring / Diagnostic Solutions
14.3. Remote Digital Monitoring / Diagnostic Solutions: Overall Market Landscape
14.4. Remote Digital Monitoring / Diagnostic Solutions: List of Developers
14.5. Remote Digital Monitoring / Diagnostic Solutions: Company Profiles
14.6. Remote Digital Monitoring / Diagnostic Solutions: Funding and Investment Analysis
14.7. Concluding Remarks
15. SWOT ANALYSIS
15.1. Chapter Overview
15.2. Comparison of SWOT Factors
16. DIGITAL SOLUTIONS: RECENT TRENDS AND FUTURE OPPORTUNITIES
16.1. Chapter Overview
16.2. Prevalent Trends Related to Digital Therapeutics
16.3. Trends Shaping the Future of Digital Therapeutics
16.4. Improving the Future Health: Opportunities Beyond Digital Therapeutics
17. EXECUTIVE INSIGHTS
For more information about this report visit https://www.researchandmarkets.com/r/xopgar